Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
658.00    -7.00 (-1.05%)
Bid:
658.00
Ask:
660.00
Spread: 2.00 (0.304%)
Market Cap: £535.58m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

AGM Statement

30 Jun 2005 07:02

Bloomsbury Publishing PLC30 June 2005 30 June 2005 Bloomsbury Publishing Plc AGM Statement At today's AGM of Bloomsbury Publishing Plc, Nigel Newton, Chairman, will makethe following statement: "Bloomsbury has made good progress since the beginning of the year, in line withthe outlook statement in the company's preliminary announcement in March. "In the UK, our titles The Promise of Happiness by Justin Cartwright, Magyk byAngie Sage, The Kite Runner, by Khaled Hosseini and the paperback of The Two ofUs by Sheila Hancock have performed well. In Germany Schott's Sammelsurium(Schott's Original Miscellany) has spent most of 2005 in the Der SpeigelBestseller list and we now have a new bestseller, Die Siebte Nacht (The SeventhNight). "The integration of Walker Publishing Company, Inc. with Bloomsbury USA is wellunder way. Cost reductions and operational efficiencies have been implemented.The sales, warehousing and fulfilment operations have now been moved to VHPS,Bloomsbury USA's distributor. With the new infrastructure in place, theoperation will raise its output of titles through increasing its titleacquisition rate and the publication of its retained paperback rights beginningin 2006. "Our publishing programme in the second half of the year gets off to a strongstart with the launch of Harry Potter and the Half Blood Prince for which thepreparations are progressing in line with our expectations. The build up topublication has already stimulated increased sales of the earlier books in theseries. We will begin our biggest ever consumer advertising campaign on 4thJuly. The book will be launched at Edinburgh Castle, immediately after midnightat 00.01am on Saturday 16th July, when J K Rowling will read from the new bookin the Great Hall to an invited audience of children. The reading will be beamedby satellite transmission to television and radio stations around the world. "Also in the second half, we will publish the paperback edition in September ofJonathan Strange & Mr Norrell by Susanna Clarke and Ben Schott will be launchinga major new project with Bloomsbury in November, Schott's Almanac, which isdesigned to be a practical and entertaining annual volume, providing a biographyof the year through an intelligent analysis of the year's events. "With effect from today, Charles Black, who joined our board in June last year,will take-over the roles of Vice Chairman and senior independent non-executivedirector from Paul Scherer, who will continue as a non-executive director. Inhis new position, Charles Black will assume the Chairmanship of the RemunerationCommittee. He is already Chairman of the Audit Committee. In the next year, theboard anticipates appointing a new non-executive director. "The board continues to view the outcome of the year to be in line with marketexpectations." ENDS Enquiries: Tim Spratt/Charles PalmerFinancial Dynamics 020 7831 3113 Sandy Karon, PA to the Chief ExecutiveBloomsbury Publishing Plc 020 7494 6015 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Mar 20257:00 amRNSNotice of Trading Update
24th Feb 20254:27 pmRNSHolding(s) in Company
14th Feb 202510:05 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Jan 20257:00 amRNSBloomsbury reaches new agreement with Amazon
16th Dec 202410:05 amRNSHolding(s) in Company
16th Dec 20249:55 amRNSHolding(s) in Company - Replacement
11th Dec 202410:24 amRNSDirector/PDMR Shareholding
9th Dec 20249:18 amRNSDirector/PDMR Shareholding
26th Nov 202411:44 amRNSHolding(s) in Company
26th Nov 202410:35 amRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSUnaudited Interim Results
30th Sep 20247:00 amRNSNotice of Interim Results
2nd Sep 202411:31 amRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSDirector/PDMR Shareholding
28th Aug 202410:57 amRNSDirector/PDMR Shareholding
16th Aug 20244:18 pmRNSAMENDMENT: BLOCK LISTING SIX MONTHLY RETURN
16th Aug 20249:42 amRNSBLOCK LISTING SIX MONTHLY RETURN
7th Aug 20245:36 pmRNSAwards under the 2023 Executive Share Plan
16th Jul 20243:41 pmRNSResults of the 2024 Annual General Meeting
16th Jul 20247:00 amRNSAGM Trading Update
14th Jun 20245:01 pmRNSAnnual Financial Report
14th Jun 20241:48 pmRNSBoard Appointment
29th May 20247:00 amRNSAcquisition
23rd May 20247:00 amRNSChairman Succession Announcement
23rd May 20247:00 amRNSAudited Preliminary Results
20th May 20247:00 amRNSInvestor Presentation
16th Feb 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Feb 20247:00 amRNSTrading Update
1st Feb 20243:11 pmRNSBloomsbury launches latest Sarah J. Maas novel
15th Jan 20247:00 amRNSBloomsbury Appoints Head of Investor Relations
12th Jan 202411:45 amRNSHolding(s) in Company
9th Jan 20244:10 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
15th Nov 20237:00 amRNSBlocklisting Application
31st Oct 20237:00 amRNSInvestor Presentation
26th Oct 20237:00 amRNSUnaudited Interim Results
9th Oct 20231:00 pmRNSBloomsbury playwright Jon Fosse wins Nobel Prize
22nd Sep 20231:26 pmRNSDirector/PDMR Shareholdings - Correction
14th Sep 20237:00 amRNSBloomsbury launches new book by Katherine Rundell
5th Sep 20237:00 amRNSDirector/PDMR Shareholding
1st Sep 20232:05 pmRNSDirector/PDMR Shareholding
30th Aug 20231:56 pmRNSDirector/PDMR Shareholding
29th Aug 20232:11 pmRNSDirector/PDMR Shareholding
23rd Aug 20237:00 amRNSHolding(s) in Company
22nd Aug 20238:00 amRNSBloomsbury enjoys bestseller success
17th Aug 20234:40 pmRNSBLOCK LISTING SIX MONTHLY RETURN
18th Jul 20235:13 pmRNSResults of the 2023 Annual General Meeting
18th Jul 20237:00 amRNSAGM Trading Update
23rd Jun 20232:29 pmRNSAnnual Financial Report
2nd Jun 202311:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.